US clears first drug for tardive dyskinesia
admin 12th April 2017 Uncategorised 0Neurocrine Biosciences’ Ingrezza has become the first drug approved to treat the hyperkinetic movement disorder tardive dyskinesia in the US.
More: US clears first drug for tardive dyskinesia
Source: News